BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30637479)

  • 1. Role of Mediator in virulence and antifungal drug resistance in pathogenic fungi.
    Moran GP; Anderson MZ; Myers LC; Sullivan DJ
    Curr Genet; 2019 Jun; 65(3):621-630. PubMed ID: 30637479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the Mediator complex in fungal pathogenesis and response to antifungal agents.
    O'Connor-Moneley J; Alaalm L; Moran GP; Sullivan DJ
    Essays Biochem; 2023 Sep; 67(5):843-851. PubMed ID: 37013399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
    Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
    Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeric ORFs (TLOs) in Candida spp. Encode mediator subunits that regulate distinct virulence traits.
    Haran J; Boyle H; Hokamp K; Yeomans T; Liu Z; Church M; Fleming AB; Anderson MZ; Berman J; Myers LC; Sullivan DJ; Moran GP
    PLoS Genet; 2014 Oct; 10(10):e1004658. PubMed ID: 25356803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of the TLO gene family enhances the virulence of Candida species.
    Flanagan PR; Fletcher J; Boyle H; Sulea R; Moran GP; Sullivan DJ
    PLoS One; 2018; 13(7):e0200852. PubMed ID: 30028853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional diversification accompanies gene family expansion of MED2 homologs in Candida albicans.
    Dunn MJ; Kinney GM; Washington PM; Berman J; Anderson MZ
    PLoS Genet; 2018 Apr; 14(4):e1007326. PubMed ID: 29630599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced
    Liu Z; Myers LC
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tlo proteins are stoichiometric components of Candida albicans mediator anchored via the Med3 subunit.
    Zhang A; Petrov KO; Hyun ER; Liu Z; Gerber SA; Myers LC
    Eukaryot Cell; 2012 Jul; 11(7):874-84. PubMed ID: 22562472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison.
    Pais P; Costa C; Cavalheiro M; Romão D; Teixeira MC
    Front Cell Infect Microbiol; 2016; 6():131. PubMed ID: 27812511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of TLO Mediator Subunit Genes Facilitate Filamentous Growth in Candida Spp.
    Liu Z; Moran GP; Sullivan DJ; MacCallum DM; Myers LC
    PLoS Genet; 2016 Oct; 12(10):e1006373. PubMed ID: 27741243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression.
    Uwamahoro N; Qu Y; Jelicic B; Lo TL; Beaurepaire C; Bantun F; Quenault T; Boag PR; Ramm G; Callaghan J; Beilharz TH; Nantel A; Peleg AY; Traven A
    PLoS Genet; 2012; 8(4):e1002613. PubMed ID: 22496666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal mediator tail subunits contain classical transcriptional activation domains.
    Liu Z; Myers LC
    Mol Cell Biol; 2015 Apr; 35(8):1363-75. PubMed ID: 25645928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungals: Protein-protein interaction inhibitor tackles drug resistance.
    Kingwell K
    Nat Rev Drug Discov; 2016 Apr; 15(4):232-3. PubMed ID: 27032830
    [No Abstract]   [Full Text] [Related]  

  • 14. Mediator Tail Module Is Required for Tac1-Activated
    Liu Z; Myers LC
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipids: Regulators of azole drug resistance and fungal pathogenicity.
    Song J; Liu X; Li R
    Mol Microbiol; 2020 Dec; 114(6):891-905. PubMed ID: 32767804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of white-opaque switching by individual subunits of Candida albicans mediator.
    Zhang A; Liu Z; Myers LC
    Eukaryot Cell; 2013 Sep; 12(9):1293-304. PubMed ID: 23873866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH signaling in human fungal pathogens: a new target for antifungal strategies.
    Cornet M; Gaillardin C
    Eukaryot Cell; 2014 Mar; 13(3):342-52. PubMed ID: 24442891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.